Efficacy and tolerance of gemcitabine-based regimens in elderly patients with advanced pancreatic cancer

被引：0
|
作者：
Marechal, Raphael
Demols, Anne
Gay, France
Arvanitakis, Marianna
Hendlisz, Alain
Van Laethem, Jean-Luc
机构：
[1] Erasme Univ Hosp, B-1070 Brussels, Belgium
[2] Inst Jules Bordet, B-1000 Brussels, Belgium
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [41] Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection
    Sahora, K.
    Schindl, M.
    Kuehrer, I.
    Werba, G.
    Fitzal, F.
    Goetzinger, P.
    Gnant, M.
    EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2013, 45 (03): : 169 - 178
  • [42] Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy
    Chung, Kwang Hyun
    Ryu, Ji Kon
    Son, Jun Hyuk
    Lee, Jae Woo
    Jang, Dong Kee
    Lee, Sang Hyub
    Kim, Yong-Tae
    GUT AND LIVER, 2017, 11 (02) : 298 - 305
  • [43] Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection
    K. Sahora
    M. Schindl
    I. Kuehrer
    G. Werba
    F. Fitzal
    P. Goetzinger
    M. Gnant
    European Surgery, 2013, 45 : 169 - 178
  • [44] Overall Survival of Patients with Advanced Pancreatic Cancer Improved with an Increase in Second-Line Chemotherapy after Gemcitabine-Based Therapy
    Zhang, Yuan-Dong
    Yang, Qiong
    Jiang, Zhi-min
    Ma, Wen
    Zhou, Si-wei
    Xie, De-rong
    JOURNAL OF THE PANCREAS, 2011, 12 (02): : 131 - 137
  • [45] Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy
    T Hamada
    Y Nakai
    H Yasunaga
    H Isayama
    H Matsui
    N Takahara
    T Sasaki
    K Takagi
    T Watanabe
    H Yagioka
    H Kogure
    T Arizumi
    N Yamamoto
    Y Ito
    K Hirano
    T Tsujino
    M Tada
    K Koike
    British Journal of Cancer, 2014, 110 : 1943 - 1949
  • [46] Inflammatory marker levels and prediction of patient-reported symptoms in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy
    Wang, Xin Shelley
    Shi, Qiuling
    Li, Donghui
    Eng, Cathy
    Bokhari, Raza H.
    Fogelman, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] Cumulative meta-analysis of randomized trials comparing gemcitabine-based chemotherapy versus gemcitabine alone in patients with advanced or metastatic pancreatic cancer (PC).
    Banu, E
    Oudard, S
    Banu, A
    Fodor, A
    Landi, B
    Lecomte, T
    Laurent-Puig, P
    Cugnenc, PH
    Andrieu, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 333S - 333S
  • [48] Comparative Study on the Clinicopathological Effect Between Gemcitabine-Based and S-1/Gemcitabine-Based Chemoradiotherapy for Locally Advanced Pancreatic Ductal Adenocarcinoma
    Kishiwada, M.
    Kato, H.
    Murata, Y.
    Tanemura, A.
    Kuriyama, N.
    Azumi, Y.
    Mizuno, S.
    Usui, M.
    Sakurai, H.
    Isaji, S.
    PANCREAS, 2014, 43 (08) : 1379 - 1380
  • [49] Systematic review and meta-analysis of gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer
    de Jesus, Victor H. F.
    Camandaroba, Marcos P. G.
    Calsavara, Vinicius F.
    Riechelmann, Rachel P.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [50] Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy
    Hamada, T.
    Nakai, Y.
    Yasunaga, H.
    Isayama, H.
    Matsui, H.
    Takahara, N.
    Sasaki, T.
    Takagi, K.
    Watanabe, T.
    Yagioka, H.
    Kogure, H.
    Arizumi, T.
    Yamamoto, N.
    Ito, Y.
    Hirano, K.
    Tsujino, T.
    Tada, M.
    Koike, K.
    BRITISH JOURNAL OF CANCER, 2014, 110 (08) : 1943 - 1949
12345